Emtricitabine/rilpivirine/tenofovir disoproxil fumarate

Developed for: HIV infectious disease
Investigated by: Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections · National Institute of Allergy and Infectious Diseases (NIAID)

today NCT01777997 · Ph 4

201320142015201620172018201920202021202220232024202520262027

Phase	Registry id	Dates	Indication	Sponsor	Status	Outcome
Phase 4	NCT01777997	Apr 2013 → Feb 2016	HIV infectious disease	Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections	Completed	No outcome recorded

Every value below carries the sentence it was read from. 1 source stands behind the page.

Field	Value	Cited text
Known as	Emtricitabine/rilpivirine/tenofovir disoproxil fumarate	ClinicalTrials.gov intervention name — accepted as the source's own label NCT01777997 ↗